NERM
AMGN icon

New England Research & Management’s Amgen AMGN Stock Holding History

New England Research & Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.3M Buy
11,880
+2,070
+21% +$709K 1.67% 13
2026
Q1 		$3.45M Buy
9,810
+3,315
+51% +$1.18M 1.46% 16
2025
Q4 		$2.13M Buy
6,495
+1,525
+31% +$484K 0.93% 38
2025
Q3 		$1.4M Buy
4,970
+350
+8% +$102K 0.64% 51
2025
Q2 		$1.29M Buy
4,620
+2,077
+82% +$588K 0.61% 56
2025
Q1 		$792K Sell
2,543
-2,926
-54% -$864K 0.4% 75
2024
Q4 		$1.43M Sell
5,469
-5,105
-48% -$1.51M 0.73% 46
2024
Q3 		$3.41M Buy
10,574
+2,510
+31% +$821K 1.6% 12
2024
Q2 		$2.52M Sell
8,064
-889
-10% -$261K 1.21% 18
2024
Q1 		$2.55M Buy
8,953
+3,153
+54% +$923K 1.25% 19
2023
Q4 		$1.67M Sell
5,800
-4,160
-42% -$1.13M 0.89% 35
2023
Q3 		$2.68M Sell
9,960
-4,270
-30% -$1.07M 1.53% 12
2023
Q2 		$3.16M Buy
14,230
+4,175
+42% +$969K 1.83% 12
2023
Q1 		$2.43M Buy
10,055
+4,775
+90% +$1.17M 1.43% 18
2022
Q4 		$1.39M Buy
+5,280
New +$1.42M 0.8% 36
2022
Q2 		– Sell
-2,660
Closed -$643K – 152
2022
Q1 		$643K Sell
2,660
-100
-4% -$23K 0.33% 91
2021
Q4 		$621K Sell
2,760
-335
-11% -$70.7K 0.3% 99
2021
Q3 		$658K Sell
3,095
-3,580
-54% -$824K 0.34% 92
2021
Q2 		$1.63M Buy
+6,675
New +$1.64M 0.84% 40
2020
Q4 		– Sell
-1,400
Closed -$356K – 151
2020
Q3 		$356K Sell
1,400
-2,329
-62% -$577K 0.26% 100
2020
Q2 		$880K Buy
3,729
+2,250
+152% +$513K 0.63% 60
2020
Q1 		$300K Buy
1,479
+525
+55% +$115K 0.26% 106
2019
Q4 		$230K Buy
+954
New +$210K 0.15% 141
2019
Q3 		– Sell
-9,762
Closed -$1.8M – 160
2019
Q2 		$1.8M Buy
9,762
+150
+2% +$26.9K 1.22% 21
2019
Q1 		$1.83M Buy
9,612
+1,450
+18% +$277K 1.23% 17
2018
Q4 		$1.59M Buy
8,162
+2,610
+47% +$509K 1.25% 17
2018
Q3 		$1.15M Buy
5,552
+800
+17% +$158K 0.75% 47
2018
Q2 		$877K Sell
4,752
-525
-10% -$92.9K 0.58% 62
2018
Q1 		$900K Sell
5,277
-350
-6% -$64.2K 0.6% 67
2017
Q4 		$979K Buy
5,627
+2,325
+70% +$411K 0.7% 57
2017
Q3 		$616K Sell
3,302
-5,643
-63% -$1,000K 0.45% 84
2017
Q2 		$1.54M Buy
8,945
+6,600
+281% +$1.07M 1.14% 19
2017
Q1 		$385K Sell
2,345
-3,620
-61% -$602K 0.3% 105
2016
Q4 		$872K Sell
5,965
-1,300
-18% -$196K 0.68% 50
2016
Q3 		$1.21M Sell
7,265
-2,075
-22% -$351K 1.02% 26
2016
Q2 		$1.42M Sell
9,340
-275
-3% -$42.8K 1.22% 17
2016
Q1 		$1.44M Sell
9,615
-4,450
-32% -$661K 1.23% 17
2015
Q4 		$2.28M Sell
14,065
-2,230
-14% -$351K 1.97% 6
2015
Q3 		$2.25M Buy
16,295
+220
+1% +$34.7K 2.14% 4
2015
Q2 		$2.47M Buy
16,075
+2,200
+16% +$352K 2.02% 3
2015
Q1 		$2.22M Buy
13,875
+6,400
+86% +$1.01M 1.91% 5
2014
Q4 		$1.19M Sell
7,475
-1,750
-19% -$273K 1.02% 18
2014
Q3 		$1.3M Sell
9,225
-5,500
-37% -$718K 1.13% 14
2014
Q2 		$1.74M Buy
14,725
+1,450
+11% +$168K 1.56% 6
2014
Q1 		$1.64M Sell
13,275
-950
-7% -$115K 1.5% 9
2013
Q4 		$1.62M Buy
+14,225
New +$1.62M 1.57% 10

Other funds holding AMGN

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFM
Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

New England Research & Management's AMGN Position: Q2 2026 in Review

New England Research & Management increased its Amgen (AMGN) stake by 21% in Q2 2026, buying an estimated $709K and bringing the position to 11,880 shares worth $4.3M. The position accounts for 1.67% of the portfolio, ranked #13.

New England Research & Management first reported a position in AMGN in Q4 2013 and has held it in 46 quarters since. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • New England Research & Management held 11,880 shares of Amgen worth $4.3M as of Q2 2026.
  • New England Research & Management bought 2,070 Amgen shares in Q2 2026, an estimated $709K.
  • Amgen made up 1.67% of New England Research & Management's portfolio in Q2 2026, its #13 holding.
  • New England Research & Management first reported a position in Amgen in Q4 2013 and has held it in 46 quarters since.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.